Men sue drug maker after developing breasts

Thirteen thousand men are suing Johnson&Johnson, saying the bipolar drug Risperdal gave them breasts, a condition known as gynecomastia.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news

Related Links:

Source: Neuropsychiatric Disease and Treatment - Category: Psychiatry Tags: Neuropsychiatric Disease and Treatment Source Type: research
AbstractPurpose of ReviewThis paper aims to provide a succinct and narrative review of key developments in the diagnostic criteria, neurobiology, and treatment of bipolar disorder (BD).Recent FindingsDepressive symptoms/episodes and cognitive dysfunction are critical mediators of human capital, quality of life, and wellness in persons with BD. Significant advances in tolerability and incremental advances in efficacy exist with antimanic agents. Bipolar depression treatment options remain suboptimal with relatively few being metabolically neutral. In silico modeling and advanced computational methods provide promise to furt...
Source: Current Behavioral Neuroscience Reports - Category: Neuroscience Source Type: research
"The worse the data on the elderly got, and the worse the potential for the FDA reaction to it got, the more J&J seemed to intensify its sales effort." So writes investigative journalist Steven Brill in his chilling, meticulously researched "docuserial" America's Most Admired Lawbreaker, concerning Johnson &Johnson's efforts to market the antipsychotic Risperdal off-label -- that is, without authorization -- to seniors with dementia and children diagnosed with pediatric bipolar disorder. The series ended its fifteen-day run on The Huffington Post last week. It follows the spring publication of Brill...
Source: Science - The Huffington Post - Category: Science Source Type: news
I want to take this issue head on, since popular “wisdom” is that problems with consumption of wheat and related grains begin and end with celiac disease. The Wheat Lobby, for instance, frequently argues that, if you do not have celiac disease, you have no business avoiding wheat and related grains. Defenders of wheat, such as those cited in this New York Times article, argue that celiac disease affects 1% of the human population, but that the other 99% of people not only can consume wheat with impunity, but can actually do so and obtain health benefits due to fiber and B vitamin content. They say that eliminat...
Source: Wheat Belly Blog - Category: Cardiology Authors: Tags: Wheat Belly Lifestyle ataxia autoimmune diabetes gluten grains Inflammation iron neuropathy skin rash Source Type: blogs
I want to take this issue head on, since popular “wisdom” is that problems with consumption of wheat and related grains begins and ends with celiac disease. The Wheat Lobby, for instance, frequently argues that, if you do not have celiac disease, you have no business avoiding wheat and related grains. Defenders of wheat, such as those cited in this New York Times article, argue that celiac disease affects 1% of the human population, but that the other 99% of people not only can consume wheat with impunity, but can actually do so and obtain health benefits due to fiber and B vitamin content. They say that elimin...
Source: Wheat Belly Blog - Category: Cardiology Authors: Tags: Wheat Belly Lifestyle ataxia autoimmune celiac glutten neuropathy Source Type: blogs
Buy ANYTHING on Amazon and support the Beauty Brains. Shop Amazon with our link Herbal Essences has a new owner I have Herbal Essences on my mind because I just saw the news that Proctor and Gamble are selling the brand to Coty. That’s right according to this story P&G is selling off some of their lesser performing brands so they can focus on their better performing (or bigger) brands. They seem to be going for a less is more strategy. Anyway, in what is rumored to be a $12 billion deal Coty will be purchasing brands like Hugo Boss perfume, Gucci, Wella and Clairol hair care plus Max Factor and Cover Girl makeup...
Source: thebeautybrains.com - Category: Consumer Health News Authors: Source Type: blogs
We describe a case of patient with a concomitant diagnosis of Klinefelter Syndrome (KS) and Tourettism. Case description A 20-year old male with genetic diagnosis of Klinefelter syndrome was referred for evaluation of tics. His motor tics began at 4-years-old with repetitive eye fluttering, progressing over the years to a constellation of uncontrollable movements including painful head jerking, limb flailing, kicking, and vocalizations including humming, nose clearing, shouts, and specific words. The tics were preceded by an urge, were temporarily suppressible, and demonstrated rebound if suppressed (video). He also suffer...
Source: Neurology - Category: Neurology Authors: Tags: Movement Disorders: Tics, Dyskinesias, and Chorea Source Type: research
In August of 2012, Johnson &Johnson paid a $181 million multi-state consumer protection settlement to resolve charges that the company marketed its antipsychotic drug Risperdal for off-label uses. In November of 2013, J&J paid $2.2 billion to resolve False Claims Act allegations related to misbranding of a number of drugs, including Risperdal. In the past month, the company faced two further blows related to Risperdal. A Philadelphia jury awarded $2.5 million to the plaintiff over J&J’s “failure to warn” about Risperdal side effects. This was the first such case to be heard by a jury, though hundreds ...
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs
David Sell Posted:   Friday, January 30, 2015, 8:05 AM Benita Pledger dabbed at her tears as she sat in a wooden chair outside a court room in Philadelphia's City Hall early Thursday evening. "I'm just having a hard time right now," she said, "hearing what the pharmaceutical company was doing." Pledger had just finished a full day of listening to her attorney, Thomas Kline, and former U.S. Food and Drug Administration commissioner Dr. David Kessler discuss documents that showed Johnson & Johnson's Janssen Pharmaceutical subsidiary tried to manipulated data in versions of report...
Source: PharmaGossip - Category: Pharmaceuticals Authors: Source Type: blogs
David SellPosted: Friday, January 30, 2015, 8:05 AMBenita Pledger dabbed at her tears as she sat in a wooden chair outside a court room in Philadelphia's City Hall early Thursday evening."I'm just having a hard time right now," she said, "hearing what the pharmaceutical company was doing."Pledger had just finished a full day of listening to her attorney, Thomas Kline, and former U.S. Food and Drug Administration commissioner Dr. David Kessler discuss documents that showed Johnson &Johnson's Janssen Pharmaceutical subsidiary tried to manipulated data in versions of reports to hide evidence that ...
Source: PharmaGossip - Category: Pharmaceuticals Authors: Source Type: blogs
More News: Bipolar | Gynecomastia | Health | Mania